Here are Top Health stories of the day
India logged 2.58 lakh Covid-19 cases and 385 deaths in last 24 hours
NEET PG 2022, NEET PG 2021 Counselling Dates Clash, Candidates Cry Foul
Pointing out the clash of dates between the NEET PG 2021 counselling and the NEET PG 2022, several candidates have taken to social media to express their protest and demand postponement of the upcoming exam.
Apart from the clash of dates, the aspirants have pointed out that when they are supposed to be preparing for the upcoming examination, they are required to attend offline counselling in other states. Besides, a large number of students are not eligible to appear in the examination as they are completing their internship in June 2022.
For more details, check out the full story on the link below:
OOPS: NEET PG 2022, NEET PG 2021 Counselling Dates Clash, Candidates Cry Foul
MBBS, BDS admissions 2021: MCC releases NEET counselling schedule for states
Through a recent notice, the Medical Counselling Committee (MCC) under DGHS has released the NEET Counselling schedule for the academic year 2021 for State UG Counselling to be conducted by respective state counselling authorities.
As for AIQ, the counselling for MBBS/ BDS/ B.SC NURSING for NEET 15% AIQ and 100% Deemed/Central Universities/ESIC/ AFMS( registration only) and AIIMS/JIPMER has begun with Round 1 Verification of Seat Matrix on 17th and 18th January. The MCC round 1 registration of candidates will begin on the 19th January,2022 and end on 24th January, 2022.
For more details, check out the full story on the link below:
MBBS, BDS Admissions 2021: MCC Releases NEET Counselling Schedule For States
NPPA to study access of medicine at affordable prices, invites proposal
The apex price regulator authority, National Pharmaceutical Pricing Authority (NPPA) has invited a proposal for conducting a study on "the drug policies of different countries to access medicine at affordable prices".
For the same the NPPA has released a public notice inviting tenders in the form of Request for Proposal (RFP) for conducting the study entitled as "To study the drug pricing policies of different countries/ region and lessons learnt from these countries/ regions in terms of access to medicine at affordable prices."
For more details, check out the full story on the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.